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Although China is a large country undergoing rapid economic
development, little information is currently available on health
disparities in this miracle economy.1 Since infectious diseases are a
major public health threat in this country,2 it is reasonable to
hypothesize that health disparities might be substantially involved
in the spread of infectious diseases in China.
To test this hypothesis, we investigated the relationship
between Chinese provincial economic growth and corresponding
incidences of infectious diseases in 2009. In this year, a total of
seven infectious diseases (hepatitis B and C, pulmonary tubercu-
losis, dysentery, syphilis, gonorrhea, and H1N1 inﬂuenza A) had a
national reported incidence number greater than 100 000. The
reported incidence rates of all seven diseases were retrieved from
the China Health Statistics Yearbook 2010 for all 31 provinces of
China.3 The per capita gross domestic product (GDP) of each
province was also compiled from the China Statistical Yearbook
2010.4 As a widely used indicator of economic development, this
measurement is deﬁned as the total market value of all ﬁnal goods
and services produced within a province in a year.
Pearson correlation analyses between the epidemiological and
economic variables provided solid evidence for our hypothesis.
Three out of the seven major infectious diseases had a close
correlation with economic growth (p < 0.01; Table 1). The reported
incidence rate of a respiratory disease, pulmonary tuberculosis,
was negatively correlated with the per capita GDP. In sharp
contrast, the incidence rates of two sexually transmitted diseases,
syphilis and gonorrhea, were positively correlated with the per
capita GDP. No associations with economic development were
detected for the remaining four diseases (hepatitis B and C,
dysentery, and H1N1 inﬂuenza A). Inter-provincial health inequi-
ties undoubtedly exist for the transmission of some infectious
diseases in China.
To our knowledge, this is the ﬁrst study to investigate the
relationship between the incidence of infectious diseases andTable 1
Pearson correlation coefﬁcient between per capita gross domestic product and
reported incidence rates of seven infectious diseases
Per capita gross domestic product
Hepatitis B 0.332
Hepatitis C 0.261
Pulmonary tuberculosis 0.595a
Dysentery 0.292
Syphilis 0.500a
Gonorrhea 0.545a
H1N1 inﬂuenza A 0.220
a p < 0.01.
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poverty and wealth could be the cause of substantial public health
problems in China. The former facilitates the transmission of
tuberculosis through malnutrition and poor living or working
conditions, as well as limited access to health services in the poor
areas, while the latter fuels sexually transmitted infections
through the rapidly expanded commercial sex industry in those
economically vibrant regions. Clearly, the differential responses of
infectious diseases to economic growth should be taken into
consideration in the development of effective public health
strategies in China.
The apparently neutral effects of economic growth on the
remaining four infectious diseases should be interpreted with
caution. Since hepatitis B has no clear transmission route in many
patients in China,5 it is very difﬁcult to speculate on the inﬂuence
that economic development will have on this disease. But the fact
that the top three high-incidence provinces are also amongst the
poorest in this country indicates the possible role of poverty in the
spread of hepatitis B. The incidence rates of hepatitis C, dysentery,
and H1N1 inﬂuenza A were uniformly low across most provinces,
while the possibility of under-reporting or over-reporting still
cannot be ruled out. Obviously, more information is necessary for
further evaluation. As pointed out previously,6,7 China is currently
experiencing rapid economic growth and widening inequalities
between rich and poor areas; the incorporation of regional
disparities into state strategies will play a key role in the control
and prevention of infectious diseases.
A limitation of this study is that the measurement unit is a
province, and therefore the intra-provincial relationship between
economic growth and infectious diseases still needs investigation.
To test this hypothesis on a local or regional scale, we are planning to
perform a similar analysis of the economic and epidemiological data
from Beijing, the capital of China, whose municipal government will
publish a white paper on the health status of its citizens.
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